DCGI extends shelf life of Covishield vaccine from 6 to 9 months
3 years, 8 months ago

DCGI extends shelf life of Covishield vaccine from 6 to 9 months

India Today  

India's drug regulator Drugs Controller General of India has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its manufacturing date. In a letter to the Serum Institute of India, Drugs Controller General of India V G Somani said the SII is permitted to apply the shelf life of nine months to unlabelled vials available on hand. The DCGI said it has no objection in respect of 'Extension of Shelf Life of Covishield Vaccine' in multi-dose glass vial from six months to nine months. "You are permitted to apply the shelf life of nine months to unlabelled vials available on hand, subject to the condition that the details of such stock, batch-wise, shall be submitted to this office and Central Drugs Laboratory, Kasauli," Somani said in the letter.

India Life Nine Months Months Shelf Dcgi Shelf Life Covishield  life  covishield  months  vaccine  drugs  shelf  extends  dcgi  unlabelled  permitted  india  vials  somani

History of this topic

SII stopped Covishield production last year; says Adar Poonawalla; claims nearly 100 million doses expired
2 years, 2 months ago

SII stopped Covishield production last year; says Adar Poonawalla; claims nearly 100 million doses expired

India TV News  

Highlights Adar Poonawalla said SII halted the production of vaccines in December 2021 Booster vaccines have no demand, Adar Poonawalla said There is general lethargy among people and they are fed up with the pandemic, Poonawalla said Serum Institute of India has stopped the production of the Covishield vaccine as there are not many takers for COVID-19 booster doses. The …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

India Today  

The government has approved Biological E's Corbevax as a precautionary dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday. "Corbevax will be considered as a precautionary dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for …

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon
2 years, 4 months ago

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon

News 18  

The Union health ministry is expected to soon approve Biological E’s Corbevax as a precaution dose for people above 18 years who are double vaccinated with either Covishield or Covaxin, official sources said on Tuesday. “Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose …

India Likely to Reduce Gap Between 2nd Covid Vaccine Shot, Booster Dose for Those Flying Abroad
2 years, 7 months ago

India Likely to Reduce Gap Between 2nd Covid Vaccine Shot, Booster Dose for Those Flying Abroad

News 18  

India may reduce the gap between the second Covid-19 vaccine shot and the precautionary third dose from nine to six months for citizens who are scheduled to travel abroad, especially to countries that have made it compulsory for travelers to produce their booster certificates. According to the advisory issued by the Union Ministry of Health and Family Welfare, the gap …

Serum Institute to Give Free Covishield Vials to Private Vaccination Centres to Compensate for Price Difference
2 years, 8 months ago

Serum Institute to Give Free Covishield Vials to Private Vaccination Centres to Compensate for Price Difference

News 18  

A day after slashing the price of the precaution dose of Covishield to Rs 225 per shot for private hospitals, the Serum Institute of India told the Centre on Sunday that it will compensate for the price difference for the unexpired stocks lying with private centres in the form of free vials of fresh stocks, official sources said. Vaccine majors …

2nd Covishield Dose Can Now Be Taken Between 8-16 Weeks After 1st Dose, No Word on Covaxin Yet
2 years, 9 months ago

2nd Covishield Dose Can Now Be Taken Between 8-16 Weeks After 1st Dose, No Word on Covaxin Yet

News 18  

The National Technical Advisory Group on Immunisation has recommended administering the second dose of Covid-19 vaccine Covishield between eight and 16 weeks after the first dose, officials said on Sunday. Under the National Covid-19 Vaccination Strategy, the second dose of Covishield is to be given between 12-16 weeks after the first dose. An official source said the latest recommendation of …

Covishield 2nd dose can be given between 8-16 weeks after 1st, instead of 12-16
2 years, 9 months ago

Covishield 2nd dose can be given between 8-16 weeks after 1st, instead of 12-16

India TV News  

Highlights NTAGI recommended administering 2nd dose of Covishield between 8-16 weeks after the first dose. Presently, the second dose of Covishield is given between 12-16 weeks after the first dose. India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose, official sources said on Sunday …

Pune: 1.24 lakh Covishield vaccines will expire within 38 days, says municipal corporation report
2 years, 10 months ago

Pune: 1.24 lakh Covishield vaccines will expire within 38 days, says municipal corporation report

India Today  

A recent Pune Municipal Corporation report has revealed that a total of 1.24 lakh Covishield vaccine doses are lying at 22 private vaccination centres and hospitals within the Pune municipal limits. Of the total 1.24 lakh jabs, about 1.09 lakh doses are lying at Jupiter hospital, which are expected to expire on March 5. 1.24 lakh Covishield vaccines to face …

Govt Panel Recommends Emergency Approval For Covid Vaccine Corbevax For 12-18 Age Group
2 years, 10 months ago

Govt Panel Recommends Emergency Approval For Covid Vaccine Corbevax For 12-18 Age Group

ABP News  

New Delhi: An expert panel of India's central drug authority recommended on Monday that Biological E's Covid-19 vaccine, Corbevax, be granted restricted emergency use authorisation for the age group 12 to 18 years, PTI reported. On December 28 last year, the Drugs Controller General of India granted emergency use authorisation to Corbevax, India's first indigenously manufactured RBD protein sub-unit vaccine …

Centre rejects reports of expired vaccines being administered in India as ‘misleading’
2 years, 11 months ago

Centre rejects reports of expired vaccines being administered in India as ‘misleading’

Hindustan Times  

The central government on Monday rejected the reports that claimed expired coronavirus disease vaccines were being administered in India under its national vaccination programme. The government said in a release that the media reports were “false and misleading and based on incomplete information.” Bharat Biotech's Covaxin vaccine is the only vaccine with emergency use listing for the 15-18 age group …

Over 40 lakh 15-18 children given COVID-19 vaccine doses on first day
2 years, 11 months ago

Over 40 lakh 15-18 children given COVID-19 vaccine doses on first day

Deccan Chronicle  

New Delhi: As India gears up to contain a new Covid-19 surge stoked by the highly infectious Omicron variant, over 40 lakh children in the 15-18 age group got their first dose of the coronavirus vaccine on Monday. Over 40 lakhs between 15-18 age received their first dose of the Covid-19 vaccine on the first day of vaccination drive for …

Reports alleging expired vaccines being administered false, misleading: Health Ministry
2 years, 11 months ago

Reports alleging expired vaccines being administered false, misleading: Health Ministry

India Today  

The Union health ministry on Monday dismissed media reports alleging that expired vaccines are being administered in the country under its COVID-19 vaccination programme as "false and misleading". "There have been some media reports alleging that expired vaccines are being administered in India under its national COVID-19 vaccination programme. On October 25, 2021, in response to Bharat Biotech International Limited's …

Give full authorisation to Covishield: Serum Institute of India
2 years, 11 months ago

Give full authorisation to Covishield: Serum Institute of India

Hindustan Times  

NEW DELHI: Pune-based Serum Institute of India on Friday announced it has applied to India’s drugs regulator for full market authorisation to Covishield, its anti-Covid vaccine, citing adequate availability of the required data. The government of India now has enough data for full market authorisation, and therefore @SerumInstIndia has applied to the @CDSCO_INDIA_INF and @MoHFW_INDIA for this permission,” Adar Poonawalla, …

Serum Institute of India applies to Indian authorities for full market authorisation of Covishield
2 years, 11 months ago

Serum Institute of India applies to Indian authorities for full market authorisation of Covishield

Firstpost  

SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine to the Indian government, which had in January this year granted emergency use authorisation in the country. New Delhi: Serum Institute of India CEO Adar Poonawala on Friday said the vaccines major has applied to Indian authorities for full market authorisation of Covishield, stating supplies …

Covishield could soon be available at medical stores as SII seeks full market authorisation nod
2 years, 11 months ago

Covishield could soon be available at medical stores as SII seeks full market authorisation nod

India TV News  

Pune-based Serum Institute of India has applied for full market authorisation for the COVID-19 vaccine Covishield with the drug regulator. SII CEO Adar Poonawala confirmed that the institute has applied for full market authorisation of the drug, stating supplies of the COVID-19 vaccine have exceeded 125 crore doses. The institute had earlier this month sought the drug regulator's approval for …

DCGI extends shelf life of Covaxin by 12 months
3 years, 1 month ago

DCGI extends shelf life of Covaxin by 12 months

India Today  

Covaxin-maker Bharat Biotech on Wednesday, November 3, received an extension of 12 months on the shelf life of the Covid vaccine. After a thorough review of sterility and stability studies, DCGI recommended approval for the extension of the shelf life of the vaccines. WATCH | Bharat Biotech's Covaxin on the brink of WHO approval "The CDSCO has approved the extension …

Centre received 65.25 crore Covishield doses, 9.1 crore Covaxin doses till September 19
3 years, 2 months ago

Centre received 65.25 crore Covishield doses, 9.1 crore Covaxin doses till September 19

India Today  

According to official documents, the Government of India received over 65.25 crore Covishield doses from Serum Institute of India and 9.1 crore doses of Covaxin from Bharat Biotech till September 19. Pune-based Serum Institute supplied 20.29 lakh doses of Covishield to the Union Ministry of Health in September as committed by Prakash Kumar Singh, the company's director of government and …

Covid-19: India likely to allow a smaller gap between two doses of Covishield
3 years, 3 months ago

Covid-19: India likely to allow a smaller gap between two doses of Covishield

Live Mint  

NEW DELHI: India is likely to allow a smaller gap between AstraZeneca COVID-19 vaccine doses for inoculations being carried out privately, in line with a court order, two sources told Reuters. Private hospitals and clinics will give their paying patients the option to receive their second dose of the vaccine four weeks after the first, down from between 12 and …

Serum Institute of India to supply nearly 22 cr doses of Covishield to Centre in October
3 years, 3 months ago

Serum Institute of India to supply nearly 22 cr doses of Covishield to Centre in October

India Today  

The Serum Institute of India has informed the Centre that it will be able to supply around 22 crore doses of Covishield in October as the Union government has announced resuming export of surplus Covid vaccines in the coming fourth quarter under the 'Vaccine Maitri' programme, official sources said. In a communication to the Centre on Monday, Prakash Kumar Singh, …

Reducing gap between two doses of Covishield being considered, say sources; Centre denies reports
3 years, 3 months ago

Reducing gap between two doses of Covishield being considered, say sources; Centre denies reports

Firstpost  

In May, the Centre further extended the gap between two doses of Covishield from 6-8 weeks to 12-16 weeks and said it was based on scientific evidence New Delhi: Reducing the gap between two doses of Covishield is being considered and it will be discussed in the National Technical Advisory Group on Immunisation in India, official sources said on Thursday. …

How Goes India’s Covid Vaccine Production? Here’s a Look at the Numbers
3 years, 4 months ago

How Goes India’s Covid Vaccine Production? Here’s a Look at the Numbers

News 18  

With Johnson and Johnson‘s single-dose Covid-19 vaccine getting approval for emergency use, India now has five vaccines to offer to its citizens. Before Johnson & Johnson, India’s drug regulator DCGI had over a month ago granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna’s COVID-19 vaccine for restricted emergency use in the country. As India gets another vaccine added …

Days after Centre's statement, Delhi and other states claim vaccine shortage
3 years, 5 months ago

Days after Centre's statement, Delhi and other states claim vaccine shortage

Hindustan Times  

Delhi has run out of its stocks for the Covishield vaccine against coronavirus disease, news agency PTI reported on Monday night, citing officials familiar with the matter. Manish Sisodia, the deputy chief minister of Delhi, also took to his official handle on Twitter to inform denizens regarding the vaccine shortage in the national capital. Highlighting that Covishield vaccine stocks have …

Serum Institute of India produces over 10 crore doses of Covishield in June
3 years, 5 months ago

Serum Institute of India produces over 10 crore doses of Covishield in June

India Today  

Fulfilling its commitment, Serum Institute of India has produced over 10 crore doses of its Covid-19 vaccine Covishield in June so far as India ramps up the pace of its vaccination drive in the face of a possible third wave of the viral infection. Read | Serum Institute begins manufacturing first batch of Covovax vaccine According to information provided to …

Mind the Gap: So What is the Ideal Interval between Two Covishield Shots?
3 years, 6 months ago

Mind the Gap: So What is the Ideal Interval between Two Covishield Shots?

News 18  

The Oxford-AstraZeneca vaccine or AZD1222 vaccine has never been out of the news. When clinical trial data from the United Kingdom, South Africa and Brazil was analysed, the vaccine efficacy was found to be 55% if two doses were administered at an interval of less than six weeks and around 80% if administered with a 12-week gap. The National Technical …

India aims to procure around 25 cr Covid vaccine doses in two months: Report
3 years, 6 months ago

India aims to procure around 25 cr Covid vaccine doses in two months: Report

Live Mint  

Amid attempts to ramp up the Covid-19 vaccination drive in the country further, the Indian government on Sunday said that it targets to procure 20-25 crore coronavirus vaccine doses by July-end, and 30 crore doses in August-September, news agency ANI reported citing government sources. Pune-based Serum Institute of India will provide 10-12 crore doses of Covishield vaccine to Govt next …

Amid shortage complaints, Serum Institute promises Centre 10 crore Covishield doses in June
3 years, 6 months ago

Amid shortage complaints, Serum Institute promises Centre 10 crore Covishield doses in June

India TV News  

Serum Institute of India has informed the government that it will be able to manufacture and supply nine to 10 crore doses of Covishield in June, official sources said on Sunday amid complaint by states about the shortage of anti-coronavirus vaccine jabs. "We are pleased to inform that in the month of June we will be able to manufacture and …

Covishield Gap Reduced for Keralites Travelling Abroad, Govt to Issue Vaccine Docus with Passport Numbers
3 years, 6 months ago

Covishield Gap Reduced for Keralites Travelling Abroad, Govt to Issue Vaccine Docus with Passport Numbers

News 18  

The Kerala government on Friday decided to issue a Covid-19 vaccination certificate with passport numbers to those who require to travel abroad for purposes such as jobs or higher studies. According to the order, a person who took Covishield jab and wants to get travel clearance will be eligible for second dose after four to six weeks. Since currently Covid-19 …

CoWin portal reconfigured to reflect longer interval between two Covishield doses
3 years, 7 months ago

CoWin portal reconfigured to reflect longer interval between two Covishield doses

India Today  

The CoWin digital portal for vaccination has been reconfigured to reflect changes in the dose interval of Covishield vaccine to 12-16 weeks. The Union health ministry said requisite changes have now been done in the CoWin digital portal, as a result of which further online or on-site appointments will not be possible if the period after first dose date for …

Vaccination for 45-plus Stopped for Three Days in Gujarat
3 years, 7 months ago

Vaccination for 45-plus Stopped for Three Days in Gujarat

News 18  

Inoculation of people in the age group 45 and above in Gujarat was halted for three days from Friday following a revision in the COVID-19 vaccination schedule after the Centre’s decision to increase the gap between two doses of Covishield, the state government said. However, during these three days, vaccination will continue for people in the age group of 18 …

Gap between two doses of Covishield extended to 12-16 weeks, says government
3 years, 7 months ago

Gap between two doses of Covishield extended to 12-16 weeks, says government

The Hindu  

The Union government has accepted the recommendation for extension of the gap between the first and second doses of Covishield vaccine to 12-16 weeks. Arora recommended increasing the dosing interval to 12-16 weeks between two doses of Covishield vaccine while suggesting no change in interval of Covaxin vaccine doses.’’ The panel had also recommended that those infected with COVID-19 should …

Gap between two doses of Covishield Covid vaccine extended to 12-16 weeks
3 years, 7 months ago

Gap between two doses of Covishield Covid vaccine extended to 12-16 weeks

India TV News  

The Centre on Thursday said that the gap between two doses of Covishield Covid vaccine can be increased from 12-16 weeks. The present gap between the two doses of Covishield vaccine is 6-8 weeks. "The recommendation of the COVID Working Group was accepted by the National Expert Group on Vaccine Administration for Covid-19, headed by Dr V K Paul, Member …

Health Ministry Accepts Proposal To Increase Gap Between 2 Covishield Doses To 12-16 Weeks
3 years, 7 months ago

Health Ministry Accepts Proposal To Increase Gap Between 2 Covishield Doses To 12-16 Weeks

News 18  

The Union health ministry agreed on Thursday to extend the gap between two doses of Serum Institute of India ’s Covishield to 12-16 weeks, acting on the recommendation by an advisory group on Covid-19 vaccines in India. “Based on the available real-life evidences, particularly from the UK, the COVID-19 Working Group agreed for increasing the dosing interval to 12-16 weeks …

Centre accepts Covid working group recommendation: Second Covishield dose gap increased to 12-16 weeks
3 years, 7 months ago

Centre accepts Covid working group recommendation: Second Covishield dose gap increased to 12-16 weeks

India Today  

The government on Thursday accepted the recommendation by the Covid working group and has decided to increase the gap between two doses of Covishield vaccine from 6-8 weeks to 12-16 weeks. What Covid Working Group Recommended Increase the gap between two doses of Serum Institute of India's Oxford Covid-19 vaccine 'Covishield' to 12-16 weeks, a government panel had recommended. What …

Covid-19: Vaccination of people above 18 in may be delayed: Karnataka Health Minister
3 years, 7 months ago

Covid-19: Vaccination of people above 18 in may be delayed: Karnataka Health Minister

India TV News  

Vaccination of people above 18 years of age, which was supposed to start from May 1, may be delayed as the vaccines have not yet arrived, Karnataka Health Minister Dr K Sudhakar said on Friday. "We have made orders to Serum Institute in Pune for over one crore doses but the official news is that they are still not prepared …

Maharashtra demands 12 crore doses of Covishield from Serum Institute
3 years, 7 months ago

Maharashtra demands 12 crore doses of Covishield from Serum Institute

India TV News  

The Maharashtra government has demanded 12 crore vaccine doses of Covishield from the Serum Institute of India, Pune to inoculate the state's residents. In a letter addressed to SII's CEO, Adar C Poonawala, the Public Health Department said that if the state government decides to vaccinate population between 18 to 44 years of age group, then about 12 crore vaccine …

Bharat Biotech seeks DCGI's nod to extend shelf life of Covaxin
3 years, 7 months ago

Bharat Biotech seeks DCGI's nod to extend shelf life of Covaxin

India TV News  

Bharat Biotech has written to India's drug regulator seeking extension of the shelf-life of its indigenously developed COVID-19 vaccine Covaxin from six to 24 months, sources said on Sunday. The Hyderabad-based Bharat Biotech was given permission for sale and distribution of Covaxin with shelf life of six months when stored at two to eight degrees Celsius. "Now, we are herewith …

Bharat Biotech seeks DCGI's nod to extend shelf life of Covaxin
3 years, 8 months ago

Bharat Biotech seeks DCGI's nod to extend shelf life of Covaxin

India Today  

Bharat Biotech has written to the India's drug regulator seeking extension of the shelf-life of its indigenously developed Covid-19 vaccine Covaxin from six to 24 months, sources said on Sunday. The Hyderabad-based Bharat Biotech was given permission for sale and distribution of Covaxin with shelf life of six months when stored at two to eight degrees Celsius. "Now, we are …

The Hindu Explains | Is India's supply chain in place to provide COVID-19 vaccine for all adults?
3 years, 8 months ago

The Hindu Explains | Is India's supply chain in place to provide COVID-19 vaccine for all adults?

The Hindu  

The story so far: Since April 1, the number of COVID-19 cases reported daily has been accelerating rapidly in India. On the other hand, States such as Uttar Pradesh, Gujarat, Chhattisgarh, West Bengal and Madhya Pradesh, which did not experience high daily cases last year, are now witnessing a surge. Despite the number of cases reported on April 23 reaching …

Coronavirus | Covishield to be sold to States at ₹400 a dose and at ₹600 to private hospitals from May 1
3 years, 8 months ago

Coronavirus | Covishield to be sold to States at ₹400 a dose and at ₹600 to private hospitals from May 1

The Hindu  

From May 1, Serum Institute of India will be selling Covishield to State governments at ₹400 dose and to private hospitals at ₹600 dose, Adar Poonawala, CEO, SII said in a statement on Wednesday. On Monday, when announcing vaccination for all above 18, the Centre said vaccine companies could sell half their approved lot of vaccines in the open market, …

WHO rejects Serum Institute's proposal seeking extension of Covishield shelf life from 6 to 9 months
3 years, 8 months ago

WHO rejects Serum Institute's proposal seeking extension of Covishield shelf life from 6 to 9 months

India Today  

The WHO has rejected Serum Institute of India's proposal seeking extension of the shelf life of Oxford-AstraZeneca Covid-19 vaccine, Covishield, from six to nine months, citing insufficient data, sources said. The move comes even as India's drug regulator has extended Covishield's shelf life from six to nine months from its manufacturing date. The DCGI in a letter to SII in …

Covishield supply to poor nations delayed as India battles second wave of covid
3 years, 8 months ago

Covishield supply to poor nations delayed as India battles second wave of covid

Live Mint  

New Delhi: As India battles a new wave of covid-19 infections, deliveries of vaccines produced by the Serum Institute of India to lower-income economies will face delays during March and April, the World Health Organisation has said. The Oxford University-AstraZeneca covid-19 vaccine, manufactured by SII, is available in India under brand name Covishield, which is part of the nationwide covid-19 …

Increase gap between Covishield vaccine doses to 4-8 weeks, Centre tells states
3 years, 9 months ago

Increase gap between Covishield vaccine doses to 4-8 weeks, Centre tells states

Firstpost  

New Delhi: The Centre Monday revised the time window within which the 2nd dose of Covishield vaccine can be taken, asking all states and Union Territories to administer it between 4-8 weeks instead of 4-6 weeks. COVISHIELD has been revisited by the National Technical Advisory Group on Immunisation and subsequently by NEGVAC in its 20th meeting during which the recommendation …

Centre tells States to increase interval between Covishield doses
3 years, 9 months ago

Centre tells States to increase interval between Covishield doses

The Hindu  

The Centre on Monday wrote to States/UTs to increase the interval between two doses of Covishield to 4-8 weeks, stating that there is evidence of increased protection if the second dose of Covishield is administered between 6-8 weeks after the first dose. “During this meeting, the recommendation has been revised to provide second dose of Covishield at 4-8 weeks’ interval …

Interval Period Between 2 Covishield Doses Increased to 4-8 Weeks
3 years, 9 months ago

Interval Period Between 2 Covishield Doses Increased to 4-8 Weeks

The Quint  

The Union Health Secretary Shri Rajesh Bhushan wrote to the Chief Secretaries of all States and Union Territories on Monday, 22 March, and directed them to increase the interval period between the two doses of Covishield to four-eight weeks. A press release by the government read, “The Union Health Secretary has urged the States and UTs to instruct the concerned …

Govt revises dose interval for Oxford-AstraZeneca's Covishield vaccine upto 8 weeks
3 years, 9 months ago

Govt revises dose interval for Oxford-AstraZeneca's Covishield vaccine upto 8 weeks

India TV News  

The government on Monday revised the interval between two doses of Oxford-AstraZeneca's Covishield vaccine. In a letter written by Union Health Secretary Rajesh Bhushan to the Chief Secretaries of States/UTs today, he has noted that the Ministry of Health and Family Welfare has accepted the recommendations of NTAGI and NEGVAC and has thereafter advised the States and UTs to ensure …

Centre asks state govts to increase gap between Covishield vaccine doses to 6-8 weeks
3 years, 9 months ago

Centre asks state govts to increase gap between Covishield vaccine doses to 6-8 weeks

India Today  

The Centre has asked the state and union territory governments to increase the interval between the two doses of Covishield vaccine and make it 6-8 weeks based on the recommendation of two expert panels. Now, the expert panels have recommended to administer the second dose of Covishield vaccine at 4-8 weeks’ interval after the first dose, instead of the earlier …

India's pre-produced Covid vaccines in 6-month race against expiry
3 years, 10 months ago

India's pre-produced Covid vaccines in 6-month race against expiry

India Today  

The pre-produced Covid-19 vaccines in India need to be administered before they cross their six-month expiry date — a challenging task considering the number of Indian citizens who need to be vaccinated against Covid-19. Both the Covid-19 vaccines — Serum-Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin — that are being administered as part of the country’s extensive vaccination programme have an …

How Oxford Scientists Developed AstraZeneca's 'Covishield' Vaccine in Record Time
3 years, 11 months ago

How Oxford Scientists Developed AstraZeneca's 'Covishield' Vaccine in Record Time

News 18  

As the world’s largest vaccination drive is about to start in India on Saturday, one of the two vaccines approved so far has been Oxford-AstraZeneca’s ‘Covishield.’ ‘Covishield’ has been manufactured in Serum Institute of India, in Pune. According to sources, 95 per cent of the 1.1 crore doses of Covishield vaccine purchased by the government have been delivered and shipped …

Vaccinate, but insist on Covishield, TNGDA tells doctors
3 years, 11 months ago

Vaccinate, but insist on Covishield, TNGDA tells doctors

The Hindu  

The Tamil Nadu Government Doctors Association has recommended to doctors to get the COVID-19 vaccination, and insist on the Covishield vaccine till the phase-3 results of Covaxin are out. However, as some doctors expressed concerns over the safety of the COVID-19 vaccine and expressed an unwillingness to vaccine, the TNGDA sought the opinion of three independent specialists on the safety, …

Discover Related